-
@ English News
2025-05-22 21:14:36Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025 https://financialpost.com/globe-newswire/boehringer-ingelheim-to-present-early-clinical-evidence-of-innate-immune-modulation-and-anti-tumor-activity-via-sirp%ce%b1-blockade-in-two-ongoing-trials-at-asco-2025